Portfolio company Deep Longevity went public via SEHK:0575.HK.
Added recently
Develops explainable AI systems and aging-clock technologies that combine biological and behavioral biomarkers to estimate biological age and track aging across molecular, cellular, tissue, organ, physiological, and psychological levels
Develops explainable AI systems and aging-clock technologies that combine biological and behavioral biomarkers to estimate biological age and track aging across molecular, cellular, tissue, organ, physiological, and psychological levels. Its SaaS and Longevity-as-a-Service platforms provide reports, insights, and personalized recommendations for consumers, employers, providers, insurers, and life-science organizations. The company also offers a blood-based biological-age platform and telehealth/